Clinical

The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.

Latest News

AJMC Q&A with Harsh Parmar, MD | Background image credit: ipopba - stock.adobe.com
The Role of Transplant in the Era of Novel MM Therapies: Harsh Parmar, MD

May 17th 2025

Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't replaced stem cell transplantation, Harsh Parmar, MD, of Hackensack University Medical Center, explains.

Among patients in the real-world setting, acalabrutinib was associated with reduced risks of AF or flutter and a reduced risk of hypertension. | Image credit: inthasone - stock.adobe.com
Lower Risk of Cardiovascular Events With Acalabrutinib vs Ibrutinib in CLL in Real-World Study

May 17th 2025

Overall, there were 36 factors identified as having a prognostic impact on at least 1 clinical outcome. | Image Credit: laszlo - stock.adobe.com
Review Identifies Top Prognostic Factors in Third-Line or Later DLBCL

May 16th 2025

Hospital exterior | Image Credit: Spiroview Inc. - stock.adobe.com
Access to Minimally Invasive Surgery for Advanced Ovarian Cancer Varies Widely by Facility

May 16th 2025

FDA headquarters | Image Credit: Tada Images - stock.adobe.com
Retifanlimab Becomes First FDA-Approved Frontline Treatment for Advanced Anal Cancer

May 16th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo